- Home
- HTH vs SLNO Comparison
HTH vs SLNO Comparison
Compare HTH & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTH | SLNO |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HTH | SLNO |
|---|---|---|
| Price | $33.94 | $45.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $34.00 | ★ $110.90 |
| AVG Volume (30 Days) | 365.2K | ★ 1.3M |
| Earning Date | 01-29-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ 53.28 | N/A |
| EPS | ★ 2.50 | N/A |
| Revenue | ★ $1,259,399,000.00 | $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.64 | $155.86 |
| P/E Ratio | $13.58 | ★ N/A |
| Revenue Growth | ★ 7.66 | N/A |
| 52 Week Low | $26.67 | $41.50 |
| 52 Week High | $36.14 | $90.32 |
Technical Indicators
Market Signals| Indicator | HTH | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 37.25 |
| Support Level | $34.27 | $47.01 |
| Resistance Level | $35.37 | $49.75 |
| Average True Range (ATR) | 0.50 | 2.35 |
| MACD | -0.15 | -0.13 |
| Stochastic Oscillator | 6.11 | 8.07 |
Price Performance
Historical ComparisonAbout HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.